Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VTYX |
---|---|---|
09:32 ET | 17013 | 2.165 |
09:34 ET | 400 | 2.17 |
09:36 ET | 8852 | 2.15 |
09:38 ET | 1790 | 2.15 |
09:39 ET | 200 | 2.155 |
09:41 ET | 1071 | 2.15 |
09:43 ET | 1815 | 2.16 |
09:45 ET | 300 | 2.16 |
09:48 ET | 6931 | 2.1157 |
09:50 ET | 2742 | 2.11 |
09:52 ET | 10566 | 2.09 |
09:54 ET | 3899 | 2.09 |
09:56 ET | 200 | 2.09 |
09:57 ET | 806 | 2.08 |
09:59 ET | 1150 | 2.08 |
10:01 ET | 2612 | 2.08 |
10:03 ET | 934 | 2.08 |
10:06 ET | 2179 | 2.07 |
10:08 ET | 4282 | 2.07 |
10:10 ET | 4128 | 2.085 |
10:14 ET | 300 | 2.085 |
10:15 ET | 300 | 2.085 |
10:17 ET | 600 | 2.08 |
10:19 ET | 2750 | 2.085 |
10:21 ET | 4489 | 2.085 |
10:26 ET | 1400 | 2.095 |
10:28 ET | 621 | 2.0993 |
10:30 ET | 2075 | 2.11 |
10:32 ET | 7441 | 2.1293 |
10:33 ET | 200 | 2.125 |
10:35 ET | 2300 | 2.125 |
10:37 ET | 300 | 2.13 |
10:39 ET | 1800 | 2.125 |
10:42 ET | 200 | 2.125 |
10:44 ET | 759 | 2.125 |
10:46 ET | 200 | 2.125 |
10:48 ET | 1954 | 2.1308 |
10:50 ET | 422 | 2.135 |
10:51 ET | 600 | 2.13 |
10:53 ET | 699 | 2.13 |
10:55 ET | 9035 | 2.1351 |
10:57 ET | 4557 | 2.125 |
11:00 ET | 1000 | 2.12 |
11:02 ET | 11254 | 2.125 |
11:04 ET | 700 | 2.125 |
11:06 ET | 3464 | 2.135 |
11:08 ET | 1000 | 2.14 |
11:09 ET | 200 | 2.14 |
11:11 ET | 2300 | 2.14 |
11:13 ET | 1198 | 2.15 |
11:15 ET | 400 | 2.15 |
11:18 ET | 1640 | 2.15 |
11:20 ET | 800 | 2.15 |
11:22 ET | 200 | 2.145 |
11:24 ET | 2900 | 2.135 |
11:26 ET | 250 | 2.13 |
11:29 ET | 3700 | 2.135 |
11:31 ET | 600 | 2.135 |
11:33 ET | 754 | 2.14 |
11:36 ET | 3075 | 2.145 |
11:38 ET | 400 | 2.15 |
11:40 ET | 300 | 2.15 |
11:42 ET | 100 | 2.1492 |
11:44 ET | 500 | 2.1425 |
11:45 ET | 2706 | 2.17 |
11:47 ET | 27864 | 2.155 |
11:49 ET | 3668 | 2.18 |
11:51 ET | 1000 | 2.165 |
11:54 ET | 200 | 2.165 |
11:56 ET | 600 | 2.165 |
11:58 ET | 300 | 2.16 |
12:00 ET | 12246 | 2.145 |
12:02 ET | 600 | 2.145 |
12:03 ET | 500 | 2.145 |
12:05 ET | 5800 | 2.145 |
12:07 ET | 500 | 2.145 |
12:09 ET | 200 | 2.145 |
12:12 ET | 1380 | 2.14 |
12:14 ET | 8156 | 2.135 |
12:16 ET | 3074 | 2.145 |
12:20 ET | 1100 | 2.1493 |
12:23 ET | 700 | 2.15 |
12:25 ET | 800 | 2.145 |
12:27 ET | 400 | 2.15 |
12:30 ET | 300 | 2.15 |
12:32 ET | 1000 | 2.15 |
12:34 ET | 11457 | 2.125 |
12:36 ET | 1400 | 2.13 |
12:39 ET | 400 | 2.125 |
12:41 ET | 423 | 2.12 |
12:43 ET | 257 | 2.12 |
12:45 ET | 600 | 2.1203 |
12:48 ET | 600 | 2.125 |
12:50 ET | 2079 | 2.1208 |
12:52 ET | 600 | 2.13 |
12:54 ET | 1400 | 2.13 |
12:56 ET | 200 | 2.12 |
12:57 ET | 1062 | 2.125 |
12:59 ET | 370 | 2.1208 |
01:01 ET | 1500 | 2.125 |
01:03 ET | 900 | 2.13 |
01:06 ET | 1000 | 2.13 |
01:08 ET | 100 | 2.13 |
01:10 ET | 700 | 2.13 |
01:12 ET | 1200 | 2.13 |
01:14 ET | 371 | 2.1248 |
01:15 ET | 1318 | 2.13 |
01:17 ET | 400 | 2.125 |
01:21 ET | 800 | 2.13 |
01:24 ET | 700 | 2.13 |
01:26 ET | 700 | 2.13 |
01:28 ET | 400 | 2.125 |
01:30 ET | 200 | 2.125 |
01:32 ET | 1385 | 2.13 |
01:33 ET | 200 | 2.125 |
01:35 ET | 900 | 2.125 |
01:37 ET | 400 | 2.13 |
01:39 ET | 2088 | 2.13 |
01:44 ET | 100 | 2.125 |
01:46 ET | 1500 | 2.135 |
01:48 ET | 200 | 2.14 |
01:50 ET | 200 | 2.14 |
01:51 ET | 600 | 2.14 |
01:53 ET | 300 | 2.14 |
01:55 ET | 300 | 2.13 |
01:57 ET | 300 | 2.14 |
02:00 ET | 400 | 2.135 |
02:02 ET | 200 | 2.14 |
02:04 ET | 200 | 2.135 |
02:06 ET | 200 | 2.14 |
02:08 ET | 300 | 2.135 |
02:09 ET | 400 | 2.14 |
02:11 ET | 300 | 2.14 |
02:13 ET | 520 | 2.14 |
02:15 ET | 600 | 2.14 |
02:18 ET | 200 | 2.14 |
02:20 ET | 1335 | 2.135 |
02:22 ET | 400 | 2.14 |
02:24 ET | 300 | 2.14 |
02:26 ET | 600 | 2.14 |
02:27 ET | 300 | 2.135 |
02:29 ET | 400 | 2.14 |
02:31 ET | 400 | 2.14 |
02:33 ET | 400 | 2.14 |
02:36 ET | 600 | 2.14 |
02:38 ET | 300 | 2.135 |
02:40 ET | 100 | 2.14 |
02:42 ET | 300 | 2.14 |
02:44 ET | 500 | 2.14 |
02:45 ET | 600 | 2.1399 |
02:47 ET | 700 | 2.135 |
02:49 ET | 300 | 2.14 |
02:51 ET | 713 | 2.14 |
02:54 ET | 300 | 2.14 |
02:56 ET | 500 | 2.14 |
02:58 ET | 4861 | 2.155 |
03:02 ET | 100 | 2.155 |
03:03 ET | 2000 | 2.16 |
03:05 ET | 11704 | 2.165 |
03:07 ET | 600 | 2.165 |
03:09 ET | 3243 | 2.15 |
03:12 ET | 2600 | 2.14 |
03:14 ET | 100 | 2.14 |
03:16 ET | 1357 | 2.14 |
03:18 ET | 487 | 2.14 |
03:20 ET | 100 | 2.14 |
03:21 ET | 1578 | 2.15 |
03:23 ET | 1120 | 2.14 |
03:25 ET | 2058 | 2.15 |
03:27 ET | 400 | 2.145 |
03:30 ET | 3900 | 2.135 |
03:32 ET | 100 | 2.13 |
03:34 ET | 1581 | 2.13 |
03:36 ET | 100 | 2.13 |
03:38 ET | 100 | 2.135 |
03:39 ET | 7605 | 2.16 |
03:41 ET | 1100 | 2.16 |
03:43 ET | 900 | 2.155 |
03:45 ET | 1570 | 2.155 |
03:48 ET | 8794 | 2.1601 |
03:50 ET | 4080 | 2.18 |
03:52 ET | 2497 | 2.18 |
03:54 ET | 3100 | 2.18 |
03:56 ET | 20395 | 2.19 |
03:57 ET | 16478 | 2.185 |
03:59 ET | 103512 | 2.18 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ventyx Biosciences Inc | 153.7M | -0.7x | --- |
Biomea Fusion Inc | 152.0M | -1.2x | --- |
Achieve Life Sciences Inc | 155.9M | -3.5x | --- |
INmune Bio Inc | 154.9M | -4.1x | --- |
Vigil Neuroscience Inc | 151.5M | -1.9x | --- |
Elevation Oncology Inc | 155.7M | -2.8x | --- |
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $153.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.